Virtually All Studies Support IMRT
Dosimetric improvements influence:
Tumor control (coverage, dose escalation)
Normal tissue toxicity
The magnitude of these changes can be assessed
in pre-clinical experiments or clinical trials –
Requires
equipoise,
(difficult to achieve).
Capital intensive, Learning curve.
Over time more flexible and efficient.




